The company said that its test could overcome sensitivity issues with ultrasound and serum alpha-fetoprotein assays that are used to monitor at-risk patients.

The firm reported on Tuesday that its diagnostics revenues rose 6 percent from a year ago while its biopharma lab services revenues rose almost 2 percent.

With the certification from the NYS Clinical Laboratory Evaluation Program, the company said the test is now available throughout the US.

Eight German associations are calling for changes to be made to the European In Vitro Diagnostics Regulation (IVDR) in a bid to support the continued use of laboratory-developed tests. The ...

The firm said that its overall revenues rose 2 percent year over year and 4 percent on an organic basis with a smaller increase in its life sciences revenues.